Cure Alzheimer's Fund's Dr. Rudy Tanzi's submitted answers to Senator Hillary Rodham Clinton’s questions from the May 14, 2008, Senate Special Committee on Aging “The Future of Alzheimer’s: Breakthroughs and Challenges”
Washington, May 14, 2008 – Mapping the sequence of the genes susceptible to Alzheimer’s disease provides a novel avenue for potential treatment while also improving the ability to predict risk for Alzheimer’s early in life, Dr. Rudolph Tanzi, chairman of the Cure Alzheimer’s Fund Research Consortium, told the Senate Special Committee on Aging at a hearing today on the disease.
Award winning, national-best selling author David Shenk takes a unique look at Alzheimer’s through a series of four very-short animated films aimed at increasing the understanding of Alzheimer's disease. Cure Alzheimer’s Fund Dr. Rudy Tanzi served in an advisory role to help produce these films. They can be accessed and downloaded at the Web site. The films are free for non-commercial use by anyone at anytime.
Cure Alzheimer’s Fund co-founder Henry McCance has been invited to join the Alzheimer’s Study Group (ASG). The private, non-partisan group will be working hard through this year to form a national strategy to deal effectively with the growing tragedy of Alzheimer’s disease.
Co-chaired by former Speaker of the House and Founder of the Center for Health Transformation Newt Gingrich and former Senator and President of the New School, Bob Kerrey, the ASG is composed of a panel of notables who have committed to develop an Alzheimer’s action plan for the nation by the summer of 2008.
The Alzheimer’s Association, Cure Alzheimer’s Fund, and the Lou Ruvo Brain Institute award the Tomorrow’s Leader in Alzheimer’s Disease Research prize, honoring the legacies of two pioneering Alzheimer researchers – George G. Glenner, M.D., and Leon J. Thal, M.D. The award intends to recognize the work of promising M.D. or Ph.D. Alzheimer’s disease investigators who have made pivotal recent contributions to the goal of eliminating Alzheimer’s.
As part of a yearlong journey and fund-raising campaign that will culminate with an Everest summit attempt in May 2008, Alan Arnette is in Tibet to climb Shisha Pangma. Alan’s mother suffers from Alzheimer’s disease and Alan has incorporated a $100,000 fund-raising campaign as part of his effort to summit the world’s highest mountain. Cure Alzheimer's Fund already has received contributions on Alan’s behalf from many supporters and friends.
In May, Cure Alzheimer’s Fund moved its Massachusetts headquarters to a new location in Wellesley Hills. Our neighbor, CareScout, shares a passion for ending Alzheimer’s disease, and it has been a pleasure to get to know them and their business.
Mountaineer to Raise Awarness, Research Funding for Alzheimer's on Road Back to Everest
Boston - Embarking on a yearlong challenge that he hopes will end at the top of Mt. Everest, mountain climber Alan Arnette will take on a greater challenge along his journey, raising money for research and public awareness of Alzheimer’s disease.
Caleb Finch, Ph.D. joins Scientific Advisory Board
Dr. Finch is a professor of gerontology and biological sciences with adjunct appointments in the Department of Psychology, the Department of Physiology and the Department of Neurology at the University of Southern California. Dr. Finch’s major research interest is the study of genomic controls of mammalian development and aging.
The Road Back to Mt. Everest
Mountain climber Alan Arnette
"Standing at 27,200’ on the icy slopes of Mount Everest in 2003, I lectured myself between gags that this was it. No more. I was too old and my body was just not fit for high altitude mountaineering. After all, it was only 363 days earlier that I had stood on this exact same spot suffering convulsions and made my own decision to return to the South Col before it was too late. Those experiences have come to shape my life in ways I never imagined. They are memories I hope to never forget. And now I’m going back."
Thus writes mountain climber Alan Arnette. Alan, recently retired, is embarking on a year-long challenge to climb Mt. Everest and raise $100,000 for Cure Alzheimer's Fund.
© 2005-2014 Cure Alzheimer's Fund. All rights reserved.